This study will test the hypothesis that combining psychedelics with physical therapy in digitally enriched environments will restore the ability to recover motor function in stroke patients, even in cases where the stroke occurred months to years prior.

A Phase 1 DMT trial is currently underway at the Centre for Human Drug Research in Leiden, The Netherlands. Following the completion of the study we will move forward and investigate an intravenous sub-hallucinogenic dose of DMT in acute ischemic stroke patients, in a planned Phase 2a DMT stroke study. A second Phase 2a study is being planned for traumatic brain injury (TBI).

This overview seeks to map out drug discovery & development activity in psychedelics. Drugs currently undergoing clinical trials are presented first, while drugs that are at the discovery or preclinical stage are catalogued in the latter half of this page.Due to the large amount of data presented on this page, we recommend you explore this resource on a desktop device.